The steady positive growth rate of China's economy as well as the potential momentum of China's new growth model are encouraging European companies to remain optimistic about their long-term development in the Asian market, as well as to grasp opportunities amid the country's economic transformation.
"Philips remains optimistic about the future prospects of the Chinese professional healthcare market," the company's spokesman said.
In Denner's view, the transition of China's economic growth strategy to a more sustainable, innovative and high-quality development will favor technology companies like Bosch.
"Bosch is well-prepared by innovation technology to serve this market ... We think Bosch has very good opportunity to serve the need of the upgrade of manufacturing capabilities in China," he added.
British healthcare company GlaxoSmithKline also observed the encouraging trend, noting in its report that "in China, the authorities accelerated progress towards bringing innovative treatments to market. This included increasing the pace and frequency of reimbursement coverage, especially for oncology drugs."
KEEP INVESTING IN CHINA
Many European entrepreneurs agree that expanding investments and businesses in China is a wise and profitable option in the long term, particularly when the country is committed to opening its door wider.
In March, Bosch held a groundbreaking ceremony to mark the start of its plant expansion in the western Chinese city of Xi'an. Bosch's wholly owned subsidiary Bosch Rexroth invested around 60 million euros (about 67 million dollars) in the new center of factory automation in Asia.
【国内英语资讯:Xinhua Headlines: European enterprises bullish about growth prospect in China】相关文章:
★ 悲惨的2012年
★ 惠普吞下收购苦果
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15